Sublime

An inspiration engine for ideas

AllPeopleCollectionsArticlesAudioBooksFilesHighlightsImagesLinksNotesTextTweetsVideosSocial

Are business model blueprints for biotech being rewritten to usher in giant platform biotechs? Some signs that market for partnered programs will contract under anti-trust pressure from FTC (e.g., Sanofi/Maze). Platform biotechs, which arguably already possess generational ground floor poten... See more

Eric Dai x.com

biology

Laura Huang • 1 card

Excited to feature 23 rising stars in #biotech investing and creation. What is biotech #VC and how does one get involved? What makes a promising investment? Also—the inner workings of a deal & advice for biotechs pitching in ‘23 #biomarker https://t.co/MAvpvWaCAQ

Dylan Neel, MD PhD x.com

A new era of performance enhancement has arrived - Follistatin gene therapy - EPO peptides - Oral TRT - Neuro-peptides - GH secretagogues - BPC 157 + TB500 Have I left anything out? https://t.co/eKs9YlveDs

Biohacker

x.com

RNA competitive landscape (pvt & public companies) https://t.co/yPz40ePg1t

Paras Sharma

x.com

https://t.co/tbPng2oGLr

Rishi Mody ツ

x.com

Challenging Bryan Johnson On His “Never Die” Biohacking Protocol

youtu.be

TechBio Happenings we enjoyed seeing this week! @MorganEJanes 1/ Engineering CAR sensitivity 2/ Moderna teams up with Life Edit to develop gene editing tech 3/ Epigenetic alterations and aging 4/ Peptide barcoding for drug discovery 5/ 3D printed hear... See more

Vasudev Bailey, PhD x.com

Well produced podcasts/great intros to podcast

Alex Dobrenko • 1 card